Novel Mindfulness-Based Group Therapy Beneficial in PTSD

This article originally appeared here.
Share this content:
Novel Mindfulness-Based Group Therapy Beneficial in PTSD
Novel Mindfulness-Based Group Therapy Beneficial in PTSD

THURSDAY, April 7, 2016 (HealthDay News) -- For combat veterans with posttraumatic stress disorder (PTSD), a novel mindfulness-based group therapy is associated with increased connectivity between dorsolateral prefrontal cortex (DLPFC) regions and dorsal anterior cingulate cortex (ACC) regions, according to a study published in the April issue of Depression and Anxiety.

Anthony P. King, Ph.D., from VA Ann Arbor Health Care System in Michigan, and colleagues used mindfulness-based exposure therapy (MBET) in combat veterans with PTSD to examine potential neural correlates of mindfulness training. Twenty-three male combat veterans deployed to Afghanistan and/or Iraq with PTSD were treated with a mindfulness-based intervention (14 veterans) or an active control group therapy (present-centered group therapy [PCGT]; nine veterans).

The researchers found that veterans treated with MBET had reduced PTSD symptoms, but the effect did not differ significantly from PCGT. Following MBET there was increased default mode network (DMN) resting-state functional connectivity (posterior cingulate cortex [PCC] seed) with DLPFC regions and dorsal ACC regions associated with executive control. After therapy there was a group × time interaction showing increased connectivity with DLPFC and dorsal ACC for MBET. Improvement in PTSD avoidant and hyperarousal symptoms were seen in association PCC-DLPFC connectivity.

"Increased connectivity between DMN and executive control regions following mindfulness training could underlie increased capacity for volitional shifting of attention," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »